Understanding Diagnostic Pathways in Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

被引：0
|
作者：
Assassi, Shervin [1 ]
Shao, Nan [2 ]
Yin, Ziwei [2 ]
Volkmann, Elizabeth [3 ]
Zoz, Donald [2 ]
Leonard, Thomas [2 ]
机构：
[1] Univ Texas Houston, McGovern Med Sch, Div Rheumatol & Clin Immunogenet, Houston, TX USA
[2] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1378
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
    Vincent Cottin
    Kevin K. Brown
    Respiratory Research, 20
  • [2] Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
    Cottin, Vincent
    Brown, Kevin K.
    RESPIRATORY RESEARCH, 2019, 20 (1)
  • [3] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Cole, Alice
    Denton, Christopher P.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2022, 8 (04) : 152 - 170
  • [4] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Alice Cole
    Christopher P. Denton
    Current Treatment Options in Rheumatology, 2022, 8 : 152 - 170
  • [5] Factors prognostic of rapid progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
    Distler, Oliver
    Avouac, Jerome
    Hoffmann-Vold, Anna-Maria
    Smith, Vanessa
    Toenges, Gerrit
    Alves, Margarida
    Kuwana, Masataka
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD): the SENSCIS trial
    Prasse, A.
    Distler, O.
    Highland, K. B.
    Gahlemann, M.
    Azuma, A.
    Mayes, M. D.
    Raghu, G.
    Sauter, W.
    Girard, M.
    Alves, M.
    Clerisme-Beaty, E.
    Kuwana, M.
    Maher, T. M.
    PNEUMOLOGIE, 2020, 74 : S57 - S58
  • [7] Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): The SENSCIS Trial
    Distler, O.
    Highland, K. B.
    Gahlemann, M.
    Azuma, A.
    Fischer, A.
    Mayes, M.
    Raghu, G.
    Sauter, W.
    Girard, M.
    Alves, M.
    Clerisme-Beaty, E.
    Kuwana, M.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [8] Effect of nintedanib on circulating biomarkers in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD)*
    Prasse, Autoren A.
    Assassi, S.
    Kuwana, M.
    Denton, C.
    Maher, T.
    Diefenbach, C.
    Ittrich, C.
    Gahlemann, M.
    Distler, O.
    PNEUMOLOGIE, 2023, 77 : S53 - S54
  • [9] EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
    Assassi, S.
    Kuwana, M.
    Denton, C. P.
    Maher, T.
    Diefenbach, C.
    Ittrich, C.
    Gahlemann, M.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 719 - 720
  • [10] Nailfold Capillaroscopy in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib
    Smith, Vanessa
    Denton, Christopher
    Herrick, Ariane
    Ittrich, Carina
    Alves, Margarida
    Cutolo, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1241 - 1243
12345